INTERNATIONAL PATENT: NEUROCRINE BIOSCIENCES, INC. FILES APPLICATION FOR "OSAVAMPATOR FOR USE IN THE TREATMENT OF DEPRESSIVE DISORDERS AND COGNITIVE IMPAIRMENT"

GENEVA, Nov. 5 -- NEUROCRINE BIOSCIENCES, INC. (6027 Edgewood Bend CourtSan Diego, California 92130) filed a patent application (PCT/US2025/025568) for "OSAVAMPATOR FOR USE IN THE TREATMENT OF DEPRESSIVE DISORDERS AND COGNITIVE IMPAIRMENT" on Apr 21, 2025. With publication no. WO/2025/226581, the details related to the patent application was published on Oct 30, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): SINGH, Jaskaran B. (c/o Neurocrine Biosciences, Inc.6027 Edgewood Bend CourtSan Diego, California 92130)

Abstract: Methods of treating depressive disorders and cognitive impairment in ...